News

ABIVAX Société Anonyme (AAVXF) Q4 2023 Earnings Call Transcript

  • ABIVAX Société Anonyme (OTC:AAVXF) Q4 2023 Earnings Conference Call April 8, 2024 8:30 AM ET Company Participants Patrick Malloy - SVP, IR Marc de Garidel - CEO Sheldon Sloan - Chief Medical Officer Didier Scherrer - Chief Scientific Officer Conference Call Participants Thomas Smith - Leerink Partners Vikram Purohit - Morgan Stanley Julian Harrison - BTIG Operator Ladies and gentlemen, thank you for standing by. Welcome to ABIVAX Conference Call to discuss 2023 Financial Results and Business Update.
    04/08/2024

U.S. IPO Weekly Recap: Big Launches And New Filings Keep The IPO Market Moving

  • Both the calendar and the pipeline saw some movement this past week. Two large IPOs launched, one of which also priced, and two sizable deals submitted new filings. Eight IPOs submitted initial filings, led by three sizable names. Mach Natural Resources is currently the only IPO scheduled for the week ahead, although some small issuers may join the calendar late.
    10/21/2023
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Abivax SA American Depositary Shares (ABVX) can sell. Click on Rating Page for detail.

The price of Abivax SA American Depositary Shares (ABVX) is 15.78 and it was updated on 2024-04-27 07:00:44.

Currently Abivax SA American Depositary Shares (ABVX) is in undervalued.

News
    
News

Abivax increases size of Nasdaq uplisting deal

  • Abivax S.A. ABVX, -2.53% has increased the size of its global offering to 20.33 million shares from 18.68 million shares as part of its uplisting to the Nasdaq under the ticker symbol “ABVX” from Euronext Paris, according to a filing late Wednesday.
    Thu, Oct. 19, 2023
Unlock
ABVX Ratings Summary
ABVX Quant Ranking